SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-20-000309
Filing Date
2020-01-16
Accepted
2020-01-16 16:17:14
Documents
6
Period of Report
2020-01-16
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_011620.htm 8-K 26435
2 CERTIFICATE OF AMENDMENT TO ARTICLES OF INCORPORATION ex3-01.htm EX-3.01 3280
3 GRAPHIC ex301_001.gif GRAPHIC 77815
4 GRAPHIC ex301_002.gif GRAPHIC 171625
5 GRAPHIC ex301_003.gif GRAPHIC 153513
6 GRAPHIC ex301_004.gif GRAPHIC 53667
  Complete submission text file 0001387131-20-000309.txt   660043
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 20531143
SIC: 2834 Pharmaceutical Preparations